Pathological Biomarkers | List of Frontiers open access articles

Original Research

Published on 06 May 2022

The Altered Pattern of the Functional Connectome Related to Pathological Biomarkers in Individuals for Autism Spectrum Disorder Identification

in Brain Imaging Methods

Liling Peng
Xiao Liu
Di Ma
Xiaofeng Chen
Xiaowen Xu
Xin Gao

Frontiers in Neuroscience

doi 10.3389/fnins.2022.913377

2,677 views
10 citations

Review

Published on 18 Dec 2015

Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells

in Neural Technology

Dusica Maysinger
Jeff Ji
Eliza Hutter
Elis Cooper

Frontiers in Neuroscience

doi 10.3389/fnins.2015.00480

17,971 views
33 citations

Original Research

Published on 25 Feb 2021

Brain Structural Network Compensation Is Associated With Cognitive Impairment and Alzheimer’s Disease Pathology

in Brain Imaging Methods

Xiaoning Sheng
Haifeng Chen
Pengfei Shao
Ruomeng Qin
Hui Zhao
Yun Xu
Feng Bai
the Alzheimer’s Disease Neuroimaging Initiative

Frontiers in Neuroscience

doi 10.3389/fnins.2021.630278

6,251 views
26 citations

Review

Published on 17 Nov 2016

The Eye As a Biomarker for Alzheimer's Disease

in Neurodegeneration

Jeremiah K. H. Lim
Qiao-Xin Li
Zheng He
Algis J. Vingrys
Vickie H. Y. Wong
Nicolas Currier
Jamie Mullen
Bang V. Bui
Christine T. O. Nguyen

Frontiers in Neuroscience

doi 10.3389/fnins.2016.00536

46,641 views
176 citations

Review

Published on 04 Oct 2017

Asymmetric RNA Distribution among Cells and Their Secreted Exosomes: Biomedical Meaning and Considerations on Diagnostic Applications

in Cellular Biochemistry

Marco Ragusa
Cristina Barbagallo
Matilde Cirnigliaro
Rosalia Battaglia
Duilia Brex
Angela Caponnetto
Davide Barbagallo
Cinzia Di Pietro
Michele Purrello

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2017.00066

9,111 views
50 citations

Original Research

Published on 21 Dec 2023

Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment

in Cancer Immunity and Immunotherapy

Youlong Wang
Qi Huang
Guanqing Zhong
Jun Lv
Qinzhi Guo
Yifei Ma
Xinjia Wang
Jiling Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1191611

2,605 views

Review

Published on 05 Aug 2022

Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations

in Brain Imaging Methods

Yuto Uchida
Hirohito Kan
Keita Sakurai
Kenichi Oishi
Noriyuki Matsukawa

Frontiers in Neuroscience

doi 10.3389/fnins.2022.938092

11,833 views
71 citations

Original Research

Published on 08 Dec 2022

Identification of immune microenvironment subtypes and signature genes for Alzheimer’s disease diagnosis and risk prediction based on explainable machine learning

in Immunological Tolerance and Regulation

Yongxing Lai
Peiqiang Lin
Fan Lin
Manli Chen
Chunjin Lin
Xing Lin
Lijuan Wu
Mouwei Zheng
Jianhao Chen

Frontiers in Immunology

doi 10.3389/fimmu.2022.1046410

22,013 views
53 citations

Original Research

Published on 30 May 2025

Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment

in Cancer Immunity and Immunotherapy

Hongfang Ma
Shasha Zhang
Pengqing Jiao
Haixia Ding
Fujun Wang
Yue Zhao
Jianhua Wu
Zhanjun Guo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1553882

2,327 views

Articles

The Altered Pattern of the Functional Connectome Related to Pathological Biomarkers in Individuals for Autism Spectrum Disorder Identification

Nanoparticle-Based and Bioengineered Probes and Sensors to Detect Physiological and Pathological Biomarkers in Neural Cells

Brain Structural Network Compensation Is Associated With Cognitive Impairment and Alzheimer’s Disease Pathology

The Eye As a Biomarker for Alzheimer's Disease

Asymmetric RNA Distribution among Cells and Their Secreted Exosomes: Biomedical Meaning and Considerations on Diagnostic Applications

Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment

Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations

Identification of immune microenvironment subtypes and signature genes for Alzheimer’s disease diagnosis and risk prediction based on explainable machine learning

Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment